Dirk Thye
Chief Executive Officer bij QUINCE THERAPEUTICS, INC.
Vermogen: 730 807 $ op 31-03-2024
Profiel
Dirk Thye is the founder of Pfluent, Inc. (founded in 2011), Peninsula Pharmaceuticals, Inc. (founded in 2001), Cerexa, Inc. (founded in 2005), and Inclin, Inc. (founded in 2007).
Dr. Thye's current job is as the Chief Executive & Medical Officer, Director at Quince Therapeutics, Inc. (since 2022).
Dr. Thye's former jobs include being the President, CEO, CFO, Secretary & Director at Agenovir Corp.
(2016-2018), Chief Executive Officer & Director at Novosteo, Inc. (2021-2022), Executive Chairman at Geom Therapeutics, Inc. (2016-2020), Director at Kalyra Pharmaceuticals, Inc., Manager-Business Process at Quality Planning Corp (2007-2008), and Chief Medical Officer at Cidara Therapeutics, Inc. (2014-2016).
Dr. Thye's education includes a graduate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2024 | 689 441 ( 1.61% ) | 730 807 $ | 31-03-2024 |
Actieve functies van Dirk Thye
| Bedrijven | Functie | Begin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Chief Executive Officer | 19-05-2022 |
Eerdere bekende functies van Dirk Thye
| Bedrijven | Functie | Einde |
|---|---|---|
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Executive Officer | 01-05-2022 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Geom Therapeutics, Inc. operates as a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. The company is headquartered in San Francisco, CA. | Chairman | 01-07-2020 |
Agenovir Corp.
 Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Chief Executive Officer | 01-01-2018 |
| CIDARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02-09-2016 |
| Pfluent, Inc. | Founder | 01-03-2014 |
Opleiding van Dirk Thye
| University of California, Los Angeles | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Health Technology |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Health Technology |
Quality Planning Corp
 Quality Planning Corp Insurance Brokers/ServicesFinance Part of Verisk Analytics, Inc., Quality Planning Corp provides analytic methods to insurance companies for auto insurance ratings. The private company is based in San Francisco, CA. Quality Planning was acquired by Insurance Services Office, Inc. on January 28, 2004. | Finance |
Inclin, Inc.
 Inclin, Inc. Miscellaneous Commercial ServicesCommercial Services Inclin, Inc. engages in a pharmaceuticals and biotechnology companies. It provides biometrics, clinical operations, strategic consulting, medical writing, quality assurance, drug safety, and medical monitoring services. The company was founded by Taylor Kilfoil and Arnold Wong in 1998 and is headquartered in San Mateo, CA. | Commercial Services |
Agenovir Corp.
Agenovir Corp. Pharmaceuticals: MajorHealth Technology Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA. | Health Technology |
| Pfluent, Inc. | |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Geom Therapeutics, Inc. operates as a biotechnology company focused on the development of novel antibiotics for MDR gram-negative infections. The company is headquartered in San Francisco, CA. | Commercial Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
